A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian|Breast|SCLC|Gastric Cancers
Interventions: DRUG: Olaparib|DRUG: MEDI4736|DRUG: Bevacizumab
Sponsor: AstraZeneca
Collaborators: Iqvia Pty Ltd